Skip to main content

Table 5 Genotypes of the FTO and LEPR variants in patients with the most common LEs; statistical analysis using Fisher’s exact test (NS – not significant)

From: Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms

FTO gene polymorphism rs9939609 (c.28-23,525 T > A)

LEs

Genotypes Number of cases with LEs / without LEs

Statistical significance (Fisher’s exact test)

TT

TA

AA

Endocrine disturbances

7/29

11/47

7/24

NS

Hepatitis

9/27

4/54

10/21

p = 0.004 (AA vs. TT); p = 0.03 (AA vs. AT + TT)

Psychological abnormalities

2/34

8/50

1/30

NS

Leptin receptor gene (LEPR) polymorphism rs1137100 (K109R; c.326A > G)

LEs

Genotypes Number of cases with LEs / without LEs

Statistical significance (Fisher’s exact test)

AA

AG

GG

Endocrine disturbances

9/49

14/45

2/6

NS

Hepatitis

12/46

9/50

2/6

NS

Psychological abnormalities

8/50

4/55

0/8

NS

Leptin receptor gene (LEPR) polymorphism rs1137101 (Q223R; c.668A > G)

LEs

Genotypes Number of cases with LEs / without LEs

Statistical significance (Fisher’s exact test)

AA

AG

GG

Endocrine disturbances

16/53

5/23

4/24

NS

Hepatitis

11/58

6/22

6/22

NS

Psychological abnormalities

11/58

1/27

0/28

p = 0.03 (AA vs. GG)

Leptin receptor gene (LEPR) polymorphism rs1805094 (K656 N; c.1968G > C)

LEs

Genotypes Number of cases with LEs / without LEs

Statistical significance (Fisher’s exact test)

GG

GC

CC

Endocrine disturbances

6/19

19/80

0/1

NS

Hepatitis

3/22

19/80

1/0

NS

Psychological abnormalities

2/23

10/89

0/1

NS

  1. Statistically significant differences were found in the prevalence of hepatitis in patients with FTO gene polymorphism rs 9939609 (c.28- 23,525 T>A) – p = 0.004 (AA vs. TT); p = 0.03 (AA vs. AT + TT) and in the prevalence of psychological abnormalities in patients with LEPR polymorphism rs1137101 (Q223R; c.668A > G) – p = 0.03 (AA vs. GG)